These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 25383969)

  • 1. Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types.
    Fredriksson NJ; Ny L; Nilsson JA; Larsson E
    Nat Genet; 2014 Dec; 46(12):1258-63. PubMed ID: 25383969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of TERT promoter mutations in human cancers.
    Vinagre J; Almeida A; Pópulo H; Batista R; Lyra J; Pinto V; Coelho R; Celestino R; Prazeres H; Lima L; Melo M; da Rocha AG; Preto A; Castro P; Castro L; Pardal F; Lopes JM; Santos LL; Reis RM; Cameselle-Teijeiro J; Sobrinho-Simões M; Lima J; Máximo V; Soares P
    Nat Commun; 2013; 4():2185. PubMed ID: 23887589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.
    Wu RC; Ayhan A; Maeda D; Kim KR; Clarke BA; Shaw P; Chui MH; Rosen B; Shih IeM; Wang TL
    J Pathol; 2014 Mar; 232(4):473-81. PubMed ID: 24338723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.
    Stern JL; Theodorescu D; Vogelstein B; Papadopoulos N; Cech TR
    Genes Dev; 2015 Nov; 29(21):2219-24. PubMed ID: 26515115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
    Allory Y; Beukers W; Sagrera A; Flández M; Marqués M; Márquez M; van der Keur KA; Dyrskjot L; Lurkin I; Vermeij M; Carrato A; Lloreta J; Lorente JA; Carrillo-de Santa Pau E; Masius RG; Kogevinas M; Steyerberg EW; van Tilborg AA; Abas C; Orntoft TF; Zuiverloon TC; Malats N; Zwarthoff EC; Real FX
    Eur Urol; 2014 Feb; 65(2):360-6. PubMed ID: 24018021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly recurrent TERT promoter mutations in human melanoma.
    Huang FW; Hodis E; Xu MJ; Kryukov GV; Chin L; Garraway LA
    Science; 2013 Feb; 339(6122):957-9. PubMed ID: 23348506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes.
    Luo Z; Wang W; Li F; Songyang Z; Feng X; Xin C; Dai Z; Xiong Y
    Mol Cancer; 2019 Jun; 18(1):106. PubMed ID: 31179925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TERT biology and function in cancer: beyond immortalisation.
    Pestana A; Vinagre J; Sobrinho-Simões M; Soares P
    J Mol Endocrinol; 2017 Feb; 58(2):R129-R146. PubMed ID: 28057768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered TERT promoter and other genomic regulatory elements: occurrence and impact.
    Heidenreich B; Kumar R
    Int J Cancer; 2017 Sep; 141(5):867-876. PubMed ID: 28407294
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Colebatch AJ; Dobrovic A; Cooper WA
    J Clin Pathol; 2019 Apr; 72(4):281-284. PubMed ID: 30696697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TERT Promoter Mutations Enhance Telomerase Activation by Long-Range Chromatin Interactions.
    Min J; Shay JW
    Cancer Discov; 2016 Nov; 6(11):1212-1214. PubMed ID: 27807101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.
    Nault JC; Calderaro J; Di Tommaso L; Balabaud C; Zafrani ES; Bioulac-Sage P; Roncalli M; Zucman-Rossi J
    Hepatology; 2014 Dec; 60(6):1983-92. PubMed ID: 25123086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An interaction proteomics survey of transcription factor binding at recurrent TERT promoter mutations.
    Makowski MM; Willems E; Fang J; Choi J; Zhang T; Jansen PW; Brown KM; Vermeulen M
    Proteomics; 2016 Feb; 16(3):417-26. PubMed ID: 26553150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide analysis of noncoding regulatory mutations in cancer.
    Weinhold N; Jacobsen A; Schultz N; Sander C; Lee W
    Nat Genet; 2014 Nov; 46(11):1160-5. PubMed ID: 25261935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pan-Cancer Study of Somatic TERT Promoter Mutations and Amplification in 30,773 Tumors Profiled by Clinical Genomic Sequencing.
    Gupta S; Vanderbilt CM; Lin YT; Benhamida JK; Jungbluth AA; Rana S; Momeni-Boroujeni A; Chang JC; Mcfarlane T; Salazar P; Mullaney K; Middha S; Zehir A; Gopalan A; Bale TA; Ganly I; Arcila ME; Benayed R; Berger MF; Ladanyi M; Dogan S
    J Mol Diagn; 2021 Feb; 23(2):253-263. PubMed ID: 33285287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TERT promoter mutations in cancer development.
    Heidenreich B; Rachakonda PS; Hemminki K; Kumar R
    Curr Opin Genet Dev; 2014 Feb; 24():30-7. PubMed ID: 24657534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global analysis of somatic structural genomic alterations and their impact on gene expression in diverse human cancers.
    Alaei-Mahabadi B; Bhadury J; Karlsson JW; Nilsson JA; Larsson E
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13768-13773. PubMed ID: 27856756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: a genomic and molecular study.
    Wu S; Huang P; Li C; Huang Y; Li X; Wang Y; Chen C; Lv Z; Tang A; Sun X; Lu J; Li W; Zhou J; Gui Y; Zhou F; Wang D; Cai Z
    Eur Urol; 2014 Feb; 65(2):274-7. PubMed ID: 24215939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TERT promoter mutations in thyroid cancer.
    Liu R; Xing M
    Endocr Relat Cancer; 2016 Mar; 23(3):R143-55. PubMed ID: 26733501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.
    Cevik D; Yildiz G; Ozturk M
    World J Gastroenterol; 2015 Jan; 21(1):311-7. PubMed ID: 25574106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.